BAŞ, O. Et Al. 2020. Pembrolizumab- and/or pazopanib-induced remitting seronegative symmetrical synovitis with pitting edema in a patient with renal cell carcinoma. JOURNAL OF ONCOLOGY PHARMACY PRACTICE , vol.26, no.5 , 1230-1233.

BAŞ, O., Ozbek, A., Guven, D., Aktepe, O., KILIÇ, L., KERTMEN, N., ... ERMAN, M.(2020). Pembrolizumab- and/or pazopanib-induced remitting seronegative symmetrical synovitis with pitting edema in a patient with renal cell carcinoma. JOURNAL OF ONCOLOGY PHARMACY PRACTICE , vol.26, no.5, 1230-1233.

BAŞ, ONUR Et Al. "Pembrolizumab- and/or pazopanib-induced remitting seronegative symmetrical synovitis with pitting edema in a patient with renal cell carcinoma," JOURNAL OF ONCOLOGY PHARMACY PRACTICE , vol.26, no.5, 1230-1233, 2020

BAŞ, ONUR Et Al. "Pembrolizumab- and/or pazopanib-induced remitting seronegative symmetrical synovitis with pitting edema in a patient with renal cell carcinoma." JOURNAL OF ONCOLOGY PHARMACY PRACTICE , vol.26, no.5, pp.1230-1233, 2020

BAŞ, O. Et Al. (2020) . "Pembrolizumab- and/or pazopanib-induced remitting seronegative symmetrical synovitis with pitting edema in a patient with renal cell carcinoma." JOURNAL OF ONCOLOGY PHARMACY PRACTICE , vol.26, no.5, pp.1230-1233.

@article{article, author={ONUR BAŞ Et Al. }, title={Pembrolizumab- and/or pazopanib-induced remitting seronegative symmetrical synovitis with pitting edema in a patient with renal cell carcinoma}, journal={JOURNAL OF ONCOLOGY PHARMACY PRACTICE}, year=2020, pages={1230-1233} }